K2M Group Holdings, Inc. (NASDAQ:KTWO)‘s stock had its “buy” rating reaffirmed by equities research analysts at Oppenheimer Holdings, Inc. in a research report issued on Friday. They currently have a $24.00 price target on the medical device company’s stock. Oppenheimer Holdings, Inc.’s price objective suggests a potential upside of 29.17% from the stock’s current price.

A number of other equities analysts also recently commented on the stock. Piper Jaffray Companies reiterated a “buy” rating and set a $28.00 target price on shares of K2M Group Holdings in a research note on Friday, November 3rd. Needham & Company LLC lowered their target price on shares of K2M Group Holdings from $27.00 to $26.00 and set a “strong-buy” rating for the company in a research note on Thursday, November 2nd. JMP Securities reiterated an “outperform” rating and set a $25.00 target price (down previously from $30.00) on shares of K2M Group Holdings in a research note on Tuesday, October 10th. Cowen and Company reiterated an “outperform” rating and set a $22.00 target price (down previously from $28.00) on shares of K2M Group Holdings in a research note on Tuesday, October 10th. Finally, William Blair reissued an “outperform” rating on shares of K2M Group Holdings in a research report on Tuesday, October 10th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $25.00.

Shares of K2M Group Holdings (NASDAQ KTWO) traded down $0.29 during mid-day trading on Friday, hitting $18.58. 137,900 shares of the company were exchanged, compared to its average volume of 418,122. The company has a debt-to-equity ratio of 0.29, a current ratio of 3.06 and a quick ratio of 1.67. K2M Group Holdings has a 12-month low of $17.23 and a 12-month high of $25.99.

K2M Group Holdings (NASDAQ:KTWO) last issued its earnings results on Wednesday, November 1st. The medical device company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.01). The firm had revenue of $62.65 million for the quarter, compared to analyst estimates of $62.69 million. K2M Group Holdings had a negative return on equity of 16.02% and a negative net margin of 16.22%. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.19) EPS. sell-side analysts anticipate that K2M Group Holdings will post -0.86 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/11/13/k2m-group-holdings-inc-ktwo-rating-reiterated-by-oppenheimer-holdings-inc.html.

In other news, CFO Gregory S. Cole sold 2,350 shares of the company’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $56,588.00. Following the completion of the sale, the chief financial officer now directly owns 55,158 shares of the company’s stock, valued at $1,328,204.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider John Philip Md Kostuik sold 1,332 shares of the company’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $23.30, for a total transaction of $31,035.60. Following the completion of the sale, the insider now directly owns 200,629 shares of the company’s stock, valued at $4,674,655.70. The disclosure for this sale can be found here. Over the last three months, insiders sold 4,772 shares of company stock valued at $113,871. 5.80% of the stock is owned by corporate insiders.

Several large investors have recently made changes to their positions in KTWO. TimesSquare Capital Management LLC raised its holdings in shares of K2M Group Holdings by 31.5% in the second quarter. TimesSquare Capital Management LLC now owns 2,888,020 shares of the medical device company’s stock valued at $70,352,000 after buying an additional 691,000 shares during the last quarter. Elk Creek Partners LLC purchased a new stake in shares of K2M Group Holdings in the third quarter valued at about $7,836,000. Prudential Financial Inc. purchased a new stake in shares of K2M Group Holdings in the second quarter valued at about $6,595,000. Artemis Investment Management LLP raised its holdings in shares of K2M Group Holdings by 255.4% in the second quarter. Artemis Investment Management LLP now owns 316,703 shares of the medical device company’s stock valued at $7,716,000 after buying an additional 227,582 shares during the last quarter. Finally, State Street Corp raised its holdings in shares of K2M Group Holdings by 39.8% in the second quarter. State Street Corp now owns 713,257 shares of the medical device company’s stock valued at $17,378,000 after buying an additional 203,067 shares during the last quarter. 99.92% of the stock is owned by institutional investors and hedge funds.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.